Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Procaps Group ( (PROCF) ) has shared an update.
On May 8, 2025, Procaps Group appointed Carlos Garcia Iragorri and Manuel Vial as independent directors, following the resignations of Roberto Albisetti and Ernesto Carrizosa. This strategic move brings extensive experience to the board, with Mr. Garcia Iragorri’s background in pharmaceuticals and Mr. Vial’s expertise in retail and financial services, potentially strengthening the company’s market positioning and governance.
More about Procaps Group
Procaps Group, S.A. operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is based in Luxembourg and serves various markets, including Latin America and emerging markets.
Average Trading Volume: 1,781
Technical Sentiment Signal: Sell
Current Market Cap: $3.34B
Learn more about PROCF stock on TipRanks’ Stock Analysis page.